Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by Analyste-57on Mar 23, 2021 3:33pm
163 Views
Post# 32859853

RE:RE:RE:RE:RE:RE:RE:Slack

RE:RE:RE:RE:RE:RE:RE:Slack4Justice... The future does not look rosy for LMNL in this trial which will come in a future X, and I know what I speak, more than you all left in the ignorance by the direction of LMNL... It is not to be taken lightly this trial and not to play with the ostrich telling you that the AMF has settled everything two years ago. On the contrary, the AMF failed in its task by not wanting to seriously consider the Prometic (LMNL) case for a reason X of which I do not know, which lets me presume that the management of Prometic (LMNL today) had the long arm.
<< Previous
Bullboard Posts
Next >>